About: Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidates are APR-1051, an orally bioavailable small-molecule inhibitor of WEE1 kinase that is in Phase 1 clinical trial for the treatment of patients with advanced solid tumors with biomarkers and ATRN-119, an ATR inhibitor, which is in Phase 1/2a clinical trial for solid tumor indications. The company is headquartered in Doylestown, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.52 (+4.89%)
APRE NASDAQ Aprea Therapeutics Inc
Aprea Therapeutics Inc share price
APRE price activity
Last Price
$0.520
Change (24hr)
0.02 USD (4.89%)
Volume
55.04K
Volume (4w avg)
-
Open
$0.49
Day Range
$0.48 - $0.52
Previous Close
$0.49
Last Trade
03 Nov, 9:00 pm GMT+0
Delayed
03 Nov, 9:00 pm GMT+0
APRE price performance
Delayed
03 Nov, 9:00 pm GMT+0
APRE details
APRE Market Signals